Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v7-FR
Language English French
Date Updated 2022-04-23 2022-04-22
Drug Identification Number 02419106 02419106
Brand name COMBIVENT RESPIMAT COMBIVENT RESPIMAT
Common or Proper name COMBIVENT RESPIMAT 4ML/60 PUFF COMBIVENT RESPIMAT 4ML/60 PUFF
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients SALBUTAMOL IPRATROPIUM BROMIDE SALBUTAMOL IPRATROPIUM BROMIDE
Strength(s) 100MCG 20MCG 100MCG 20MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 4ML/600 PUFF 4ML/600 PUFF
ATC code R03AL R03AL
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-04-07 2022-04-07
Actual start date 2022-04-07 2022-04-07
Estimated end date 2022-04-26 2022-04-26
Actual end date 2022-04-22 2022-04-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Unanticipated stock out due primarily to transportation delay of replenishment order Unanticipated stock out due primarily to transportation delay of replenishment order
Health Canada comments